Kala Pharmaceuticals(KALA) - 2022 Q1 - Earnings Call Transcript

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Jill Steier - Executive Director, Investor Relations and Corporate Communications Mark Iwicki - Chairman and Chief Executive Officer Todd Bazemore - President and Chief Operating Officer Kim Brazzell - Head of R&D and Chief Medical Officer Mary Reumuth - Chief Financial Officer Conference Call Participants Christopher Neyor - JPMorgan Francois Brisebois - Oppenheimer & Co. Andreas Argyrides ...